Abstract
Recurrent neck metastases following surgery and full dose adjuvant radiotherapy of squamous cell head and neck cancer remain a clinical challenge. After revision neck dissection and chemotherapy re-irradiation dosage is often limited and survival prognosis deteriorates. Here, adjuvant high-dose rate intensity modulated perioperative brachytherapy (HDR IMBT) offers a second full radiation dose with a limited volume of normal tissue radiation in the neck. In this retrospective study patients were identified who underwent revision surgery and perioperative HDR IMBT for recurrent neck metastases. Survival rates were estimated and the scarce literature on interstitial brachytherapy of the neck was reviewed. From 2006 to 2014, nine patients were treated for recurrent or palliative neck metastases using salvage surgery and HDR IMBT. Eight patients received previous surgery and external beam radiotherapy with or without chemotherapy. Two and five year overall survival was calculated to be 78 and 67 %, respectively. HDR IMBT is a salvage treatment option for selected cases in the neck following surgical revision or last-line treatment strategies. In the literature and this small cohort radiation toxicity and the risk of “carotid blow-out” seemed to be low.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00405-015-3794-3/MediaObjects/405_2015_3794_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00405-015-3794-3/MediaObjects/405_2015_3794_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00405-015-3794-3/MediaObjects/405_2015_3794_Fig3_HTML.gif)
Similar content being viewed by others
References
Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T et al (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16:1310–1317
Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P et al (1999) Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91:2081–2086
Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098
Argiris A (2002) Update on chemoradiotherapy for head and neck cancer. Curr Opin Oncol 14:323–329
Hinerman RW, Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB (2004) Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck 26:984–994
Vokes EE, Weichselbaum RR, Lippman SM, Hong WK (1993) Head and neck cancer. N Engl J Med 328:184–194
Sher DJ, Haddad RI, Norris CM, Posner MR, Wirth LJ, Goguen LA et al (2010) Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer. Cancer 116:4761–4768
Wierzbicka M, Bartochowska A, Strnad V, Strojan P, Mendenhall WM, Harrison LB et al (2014) The role of brachytherapy in the treatment of squamous cell carcinoma of the head and neck. Eur Arch Oto-Rhino-Laryngol. doi:10.1007/s00405-014-3332-8
Mazeron J-J, Ardiet J-M, Haie-Méder C et al (2009) GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol 91:150–156
Kovács G (2015) Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy. J Contemp Brachytherapy 6:404–416
Strege R, Kovács G, Meyer J et al (2009) Perioperative intensity-modulated brachytherapy for refractory orbital rhabdomyosarcomas in children. Strahlenther Onkol 185:789–798
Strege R, Kovács G, Maune S et al (2005) Feasibility of combined operation and perioperative intensity-modulated brachytherapy of advanced/recurrent malignancies involving the skull base. Strahlenther Onkol 181:97–107
Strege R, Kovács G, Lemcke P et al (2007) Role of perioperative brachytherapy in the treatment of malignancies invading the skull base and orbit. Neurosurg Quat 17:193–207
Teudt I, Meyer J, Ritter M (2014) Perioperative image- adapted brachytherapy for the treatment of paranasal sinus and nasal cavity malignancies. Brachytherapy 13:178–186
Strnad V, Lotter M, Kreppner S, Fietkau R (2014) Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma. Brachytherapy 13:187–195
Wiegand S, Sesterhenn AM, Zimmermann AP, Strassmann G, Wilhelm T, Werner JA (2013) Interstitial HDR brachytherapy for advanced recurrent squamous cell carcinoma of the head and neck. Anticancer Res 33:249–252
Siebert F-A, Born T, Häring S et al (2006) A dosimetric analysis of interstitial intensity modulated implants for pelvic recurrences, base of tongue and orbita tumors with specific references to the ICRU-58. Radiother Oncol 79:298–303
Rudzianskas V, Inciura A, Juozaityte E, Rudzianskiene M, Kubilius R, Vaitkus S et al (2012) Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy. Acta Otorhinolaryngol Ital 32:297–303
Grimard L, Esche B, Lamothe A, Spaans JN (2009) Interstitial brachytherapy in the management of persistent head and neck disease after definitive external beam radiation therapy. Brachytherapy 8:284–289
Bartochowska A, Skowronek J, Wierzbicka M et al (2013) The role of high-dose-rate and pulsed-dose-rate brachytherapy in the management of recurrent or residual stomal tumor after total laryngectomy. Laryngoscope 123:657–661
Teckie S, Scala LM, Ho F, Wolden S, Chiu J, Cohen GN et al (2013) High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer. Brachytherapy 12:228–234
Scala LM, Hu K, Urken ML, Jacobson AS, Persky MS, Tran TN et al (2013) Intraoperative high-dose-rate radiotherapy in the management of locoregionally recurrent head and neck cancer. Head Neck 35:485–492
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481
Common Terminology Criteria for Adverse Events (CTCAE). Natl Cancer Inst 2010. http://www.eortc.be/services/doc/ctc/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf
Cohen E, Lingen M, Vokes E (2004) The expanding role of systemic therapy in head and neck cancer. J Clin Oncol 22:1743–1752
Hoo R, Grimard L, Esche B (1993) Brachytherapy of neck metastases. J Otolaryngol 22:54–57
Wibault P, Chassagne D (1977) L’endocurithérapie des récidives ganglionnaires du cou par Iridium 192 (a propos de 164 cas). Nuovo Arch Ital Otol 5:389–396
Cornes PG, Cox HJ, Rhys-Evans PR, Breach NM, Henk JM (1996) Salvage treatment for inoperable neck nodes in head and neck cancer using combined iridium-192 brachytherapy and surgical reconstruction. Br J Surg 83:1620–1622
Zelefsky M, Zimberg S, Raben A (1998) Brachytherapy for locally advanced and recurrent lymph node metastases. J Brachytherapy Int 14:123–131
Nutting C, Horlock N, A’Hern R, Searle A, Henk JM, Rhys-Evans P et al (2006) Manually after-loaded 192Ir low-dose rate brachytherapy after subtotal excision and flap reconstruction of recurrent cervical lymphadenopathy from head and neck cancer. Radiother Oncol 80:39–42
Syed AM, Feder BH, George FW, Neblett D (1978) Iridium-192 afterloaded implant in the retreatment of head and neck cancers. Br J Radiol 51:814–820
Bollet MA, Lapeyre M, Marchal C, Hoffstetter S, Peiffert D, Cornes PG et al (2001) Cervical lymph node relapses of head-and-neck squamous cell carcinoma: is brachytherapy a therapeutic option? Int J Radiat Oncol Biol Phys 51:1305–1312
Housset M, Barrett JM, Brunel P (1992) Split course interstitial brachytherapy with a source shift: the results of a new technique for salvage irradiation in recurrent inoperable cervical lymphadenopathy >4 cm diameter in 23 patients. Int J Radiat Oncol Biol Phys 22:1071–1074
Tselis N, Ratka M, Vogt H-G, Kolotas C, Baghi M, Baltas D et al (2011) Hypofractionated accelerated CT-guided interstitial 192Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer. Radiother Oncol 98:57–62
Kolotas C, Tselis N, Sommerlad M (2007) Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192 Ir HDR brachytherapy. Strahlenther Onkol 183:69–75
Pellizzon ACA, Salvajoli JV, Kowalski LP, Carvalho AL (2006) Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy. Radiat Oncol 1:27
Kupferman ME, Morrison WH, Santillan AA, Roberts D, Diaz EM, Garden AS et al (2007) The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers. Cancer 109:2052–2057
Fee WE, Goffinet DR, Paryani S, Goode RL, Levine PA, Hopp ML (1983) Intraoperative iodine 125 implants. Arch Otolaryngol 109:727–730
Stafford N, Dearnaley D (1988) Treatment of ‘inoperable’ neck nodes using surgical clearance and postoperative interstitial irradiation. Br J Surg 75:62–64
Geiger EJ, Basques BA, Chang CC, Alcon AW, Narayan D (2014) Wound healing complications with intraoperative brachytherapy for head and neck cancer. Ann Plast Surg 73:378–384
Nijdam W, Levendag P, Fuller D, Schulz R, Prevost J-B, Noever I et al (2007) Robotic radiosurgery vs. brachytherapy as a boost to intensity modulated radiotherapy for tonsillar fossa and soft palate tumors: the clinical and economic impact of an emerging technology. Technol Cancer Res Treat 6:611–620
Tagliaferri L, Bussu F, Rigante M, Gambacorta MA, Autorino R, Mattiucci GC et al (2015) Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences. Brachytherapy 14:419–425
Acknowledgments
The authors thank Eva Golabek and Adam Navel for editing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. However, due to the retrospective type of the study no formal consent was required.
Statement on the welfare of animals
This article does not contain any studies with animals performed by any of the authors.
Additional information
I. U. Teudt and G. Kovàcs contributed equally to the article.
Rights and permissions
About this article
Cite this article
Teudt, I.U., Kovàcs, G., Ritter, M. et al. Intensity modulated perioperative HDR brachytherapy for recurrent and/or advanced head and neck metastases. Eur Arch Otorhinolaryngol 273, 2707–2715 (2016). https://doi.org/10.1007/s00405-015-3794-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-015-3794-3